Initial results involving radiomics based on positron emission tomography/computed tomography (PET/CT) or CT imaging to predict PD-L1 expression status in non-small cell lung cancer, oesophageal cancer, and pancreatic cancer have shown promising results [34,35,36]. This evidence concerns the gene CD274 and familial pancreatic carcinoma.